VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,955,250 | -8.4% | 1,425,000 | -13.1% | 1.22% | -3.6% |
| Q1 2023 | $38,167,454 | +77.4% | 1,640,200 | +93.0% | 1.27% | +171.9% |
| Q4 2022 | $21,513,500 | +11.4% | 850,000 | +12.1% | 0.47% | +5.2% |
| Q2 2022 | $19,312,000 | -3.7% | 758,211 | -2.8% | 0.44% | +6.0% |
| Q1 2022 | $20,062,000 | -31.6% | 780,000 | +11.4% | 0.42% | -32.8% |
| Q4 2021 | $29,309,000 | +30.8% | 700,000 | +35.9% | 0.62% | +25.2% |
| Q3 2021 | $22,413,000 | +192.6% | 515,000 | +217.9% | 0.50% | +140.1% |
| Q2 2021 | $7,659,000 | -69.9% | 162,000 | -73.9% | 0.21% | -87.3% |
| Q2 2020 | $25,426,000 | – | 620,600 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |